分子动力学模拟显示,八氧化氨酸增强了脂质体的稳定性,隐蔽性和准性
Jingyi Zhu1, Limei Xu1, Wenxin Wang2
1State Key Laboratory of Microbial Technology, National Glycoengineering Research Center, Shandong University, Qingdao 266237, China.
ACS omega
|August 12, 2024
概括
八氧化酸 (OHA) 增强了脂质体的稳定性和药物输送的向性. 输入OHA可以改善脂质体结构,降低免疫清除,并向CD44过度表达的瘤细胞.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 基于脂质体的系统对于药物和基因传递至关重要,但面临着不稳定性和免疫清除等挑战.
- 提高脂质体性能需要创新的策略来克服这些局限性.
研究的目的:
- 为了研究氨酸 (HA) 衍生物和脂质体之间的相互作用机制.
- 评估八基化氨酸 (OHA) 在增强脂质体稳定性,减少免疫清除和改善瘤向方面的潜力.
主要方法:
- 使用了广泛的粗粒度分子动力学模拟.
- 这项研究的重点是脂质体与原生氨酸 (HA) 以及其八化衍生物 (OHA) 之间的相互作用.
主要成果:
- OHA的八基部分自发地插入脂质体双层,增强结构稳定性.
- OHA涂层中和了脂质体表面潜力,减少了蛋白质冠状形成和免疫清除.
- 封装OHA保留了对CD44的选择性,CD44是瘤细胞过度表达的标.
结论:
- OHA有效地修改脂质体,提高它们的稳定性和准能力.
- 这些发现支持开发基于脂质体的先进药物递送系统,以提高治疗疗效.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
358
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
358
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


